Skip to content

The research on the RUNGANYANGXIN decoction's clinical effect on the cardiac neurosis and the relationship with heart rate variability

The research on the RUNGANYANGXIN decoction's clinical effect on the cardiac neurosis and the relationship with heart rate variability

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200005941
Enrollment
Unknown
Registered
2022-04-28
Start date
2022-05-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac neurosis

Interventions

control group:Chinese medicine placebo plus the cognitive behavior therapy
treatment group:RUNGANYANGXIN decoction plus the cognitive behavior therapy

Sponsors

Guang'anmen Hospital of China Academy of traditional Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria:According to practical Internal Medicine (15th edition) and ICD-10, the patients in this study were included according to the following criteria according to the main points of somatic autonomic nerve dysfunction: (1) It conforms to the diagnostic criteria of cardiac neurosis, age 18-60 years old, gender unlimited. (2) It conforms to the TCM syndrome differentiation and classification criteria of heart and liver Yin deficiency type. (3) within 2 weeks before patients into groups not ?anti-anxiety?agents, antidepressants, or psychiatric drugs. (4) Patients signed informed consent.

Exclusion criteria

Exclusion criteria: Exclusion criteriaOne of the following conditions will not be included in this study. (1) Complicated with coronary heart disease, myocardium, mitral valve prolapse and other organic heart disease, ecg, 24H dynamic electrocardiogram, electrocardiograph, coronary CT, PCI examination suggested clear heart disease; (2) combined with endocrine and metabolic diseases, such as hyperthyroidism, diabetes, etc.; (3) merging other causes of ST - T period of change and unable to correct, such as hypokalemia, digitalis, or other drug reaction and "juvenile type T wave change;" (4) chronic infection or drug influence; Kidney, brain and other serious physical diseases; Epilepsy, etc. (5) with severe mental illness or family history of mental illness. (6) pregnant and lactating women or women with pregnancy wishes; (7) Had participated in another clinical trial of an investigation drug within one month prior to inclusion in this study.

Design outcomes

Primary

MeasureTime frame
Hamilton Depression Scale;Traditional Chinese Medicine symptom Score Scale;24-hour dynamic electrocardiogram;Indicators of heart rate variability;Hamilton Anxiety Scale;

Secondary

MeasureTime frame
Indicators of Psychosocial factors;Indicators of encephalofluctuograph;

Countries

China

Contacts

Public ContactXu Fengquan

Guang'anmen Hospital of China Academy of traditional Chinese Medical Sciences

xufengquan@gamyy.cn13683569369

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026